• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Osom Ultra hCG Combo Test

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Osom Ultra hCG Combo Testsee related information
Date Initiated by FirmAugust 23, 2024
Date PostedOctober 30, 2024
Recall Status1 Open3, Classified
Recall NumberZ-0259-2025
Recall Event ID 95439
510(K)NumberK944426 
Product Classification Visual, pregnancy hCG, prescription use - Product Code JHI
ProductOsom Ultra hCG Combo Test- IVD immunoassay for the qualitative detection of human chorionic gonadotropin (hCG) in serum or urine for the early confirmation of pregnancy. Model/Catalog Number: 1004
Code Information UDI-DI: 00742860100208 Lot Number: 563L13
Recalling Firm/
Manufacturer
Princeton Biomeditech Corp
4242 US Highway 1
Monmouth Junction NJ 08852-1905
For Additional Information ContactSAME
732-274-1000
Manufacturer Reason
for Recall
This recall was initiated due to customer complaints of false negative of hCG test results when running patient urine samples. Use of the above listed product lot may result in false negative results. An end user reported that the OSOM Ultra hCG Combo Test, lot 563L13, produced false negative test results from 2 patient urine samples as confirmed by quantitative hCG and ultrasound. During further root cause testing and investigation, an additional 6 devices were found to produce false negative test results from hCG positive samples.
FDA Determined
Cause 2
Process change control
ActionPBM notified the Distributor Sekisui Diagnostics on 8/23/24 via email. The sent an "URGENT PRODUCT RECALL NOTICE" dated 8/30/24 to customers. Sekisui Diagnostics issued a recall notice on 9/6/24 to its customers. PBM Letter states reason for recall, health risk and action to take: Stop distribution or use of OSOM Ultra hCG Combo Test lot 563L13. " If you have further distributed this product, please identify your customers, and notify them at once of this product recall. This recall should be carried out to the user level. Your notification to your customers may be enhanced by including a copy of this recall notification letter. " Quarantine and return any kits from the listed lots, (1) currently in your inventory, and (2) returned from your customers. " Indicate the quantity returned on the attached CONFIRMATION OF NOTIFICATION form, and follow the instructions to complete, even if you do not have any affected product remaining in your inventory. Complete, sign and return the CONFIRMATION OF NOTIFICATION form to the email provided by the date indicated on the form. Please note replacement product equivalent to the quantity of products you returned from the affected lot will be processed once the CONFIRMATION OF NOTIFICATION form has been received. If you have any questions, call PBM Technical Services at Tel 1-732-274-1000 or E-mail .
Quantity in Commerce1,860 kits (50,220 test devices)
DistributionUS Distribution to MO only.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
510(K) Database510(K)s with Product Code = JHI
-
-